Flex Pharma, Inc. (NASDAQ: FLKS) today announced that it is prioritizing its clinical programs in the severe neurological diseases of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE